Vol. I No. 1Published by Northbank Media Independent · No advertising network
The business · The Category

How men's skincare stopped being a niche in Britain

The shift is real, and it is not the one the industry describes. It happened through pharmacy, dermatology adjacency and the collapse of the gendered aisle.

Newsprint at close crop
Newsprint at close crop. The category changed faster than the coverage of it did.
The short answer

The men's grooming category in Britain historically meant shaving, deodorant and hair. What changed is not that men suddenly became vain, but that the barriers to entry fell: ingredient led products became legible, pharmacy and dermatology adjacent brands gained credibility, retail moved online where the gendered aisle does not exist, and information moved to platforms where men were willing to look. The result is a category in which the fastest growth sits in facial skincare and in professional treatment rather than in traditional grooming, and in which the distinguishing feature of a credible product is that it explains its mechanism.

The standard account of men's skincare is a story about changing masculinity. It is a comfortable story and it is largely beside the point. The more useful account is structural, and it concerns distribution, information and the collapse of a retail convention.

1. What the category used to be

For most of the twentieth century, the male personal care market in Britain consisted of shaving products, deodorant, hair products and fragrance. Facial skincare barely existed as a male category, and where it did it was positioned as aftershave balm, which is to say as an adjunct to shaving rather than as skin care in its own right.

The economics reinforced this. Shelf space was allocated by gender, the male allocation was small, and what occupied it was chosen for volume rather than for specificity. A man who wanted a moisturiser bought a product formulated for a different skin type with a different sebum profile, or he bought nothing.

2. What actually changed

Ingredients became legible. The single largest change is that consumers learned to read products by active ingredient rather than by brand promise. Retinoid, salicylic acid, niacinamide and ceramide are now terms with meaning to a general audience. That change benefits men disproportionately, because it removes the requirement to engage with a category coded as feminine and replaces it with something closer to a specification.

Retail moved online. The gendered aisle is a physical constraint. Online, a search for salicylic acid returns products regardless of which shelf they would have occupied. This is arguably the single most consequential structural change in the category.

Pharmacy and dermatology adjacency gained status. Products positioned as clinical rather than cosmetic carry a different set of connotations, and those connotations suit a male consumer who is more comfortable with a functional purchase than an aspirational one.

Professional treatment normalised. The growth in male attendance at aesthetic clinics reflects a wider change in what is discussable. It is also a market with a much higher transaction value, which is why it attracts disproportionate marketing attention.

The decisive change was not masculinity. It was the search box.

3. Where the category actually sits now

SegmentCharacterDirection of travel
ShavingMature, price competitive, subscription disruptedFlat in volume, shifting between blade formats and electric
Deodorant and bodyMature, high penetrationReformulation and format change rather than growth
Facial skincareThe growth area, increasingly ingredient ledToward specification and away from gendered branding
Sun protectionUnder-penetrated among men relative to riskThe clearest gap between need and behaviour
Hair lossLarge, telemedicine driven, unevenly evidencedGrowing, with regulatory questions unresolved
Professional treatmentHigh value, fragmented, lightly regulatedGrowing, and the subject of active UK policy work

4. The telemedicine question

The most commercially aggressive part of the male market is direct to consumer prescribing, particularly for hair loss and, increasingly, for other indications. The model routes a consumer through an online questionnaire to a prescription.

Two things are true at once. It has genuinely improved access for men who would never have attended a clinic, and the consultation quality in that model varies enormously. Where a prescription only medicine with a documented adverse effect profile is involved, as with finasteride, the standard of assessment matters. The General Medical Council has issued guidance on remote prescribing, and the position on assessing patients adequately is not ambiguous. This is discussed in male pattern hair loss.

5. The language problem the category has not solved

Men's skincare marketing still divides into two unhelpful registers. One is performance language, borrowing from engineering and sport, which sells the idea that a moisturiser is a tool rather than a cosmetic. The other is a defensive minimalism, positioning products by what they are not: no fuss, no nonsense, nothing complicated.

Both share an assumption that men need to be reassured that caring about skin is acceptable. The evidence from the category's own growth is that this reassurance is increasingly unnecessary, and that the register that actually converts is the plain description of what a product does and why. That, incidentally, is also the register that survives scrutiny.

6. Where claims outrun evidence

Three areas deserve particular scepticism.

Testosterone framing. Products that invoke testosterone or hormonal optimisation as a general explanatory mechanism are rarely making a specific, testable claim. The relevant biology is set out in androgens and male skin.

Supplements for skin and hair. A large and growing segment with a weak evidence base outside the correction of documented deficiency. Food supplements in the UK are regulated as foods rather than as medicines, so the permitted claims and the evidentiary bar are different from those applied to a licensed product.

Devices marketed for tightening. The gap between the marketing and the published evidence in this category is among the widest in the field.

The UK does have machinery for this. The Advertising Standards Authority adjudicates on misleading claims, including in cosmetics and cosmetic interventions, and its rulings are published and searchable, which makes it one of the more useful public records for anyone assessing a brand's history.

7. What would actually improve the category

Three things, none of them exotic. Clearer separation between cosmetic claims and medical claims, so that a consumer can tell whether a product is regulated as a cosmetic, a device, a food supplement or a medicine. Better labelling of what an active ingredient is present at, since concentration determines effect and is frequently withheld. And a settled regulatory position on non-surgical cosmetic procedures, which is the subject of regulating cosmetic procedures.

None of those requires men to change. They require the category to be legible, which is the same thing that drove its growth in the first place.

No commercial links on this page

This article contains no affiliate links, no sponsored placements and no links to any commercial product, brand, retailer or clinic. Nobody paid for it, nobody previewed it and nobody outside the editorial desk saw it before publication. Our editorial standards set out the three archive articles that are the single disclosed exception on this site, none of which is this one.

Nothing here is medical advice. For your own skin, speak to a pharmacist, a GP or a dermatologist.

Sources

Institution level references. We link to bodies that publish their methods, not to retailers or clinic marketing. External links open on those bodies' own sites.

  1. Advertising Standards AuthorityThe UK advertising regulator, whose published rulings cover cosmetic products and cosmetic interventions.https://www.asa.org.uk/
  2. Medicines and Healthcare products Regulatory AgencyThe UK regulator distinguishing medicines, medical devices and cosmetic products, and enforcing advertising restrictions on prescription only medicines.https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
  3. General Medical CouncilGuidance on remote consultations and prescribing, relevant to direct to consumer prescribing models.https://www.gmc-uk.org/professional-standards/professional-standards-for-doctors/remote-consultations
  4. Office for National StatisticsUK official statistics on household expenditure and retail sales, the underlying source for consumption trends.https://www.ons.gov.uk/

Frequently asked questions

Why has men's skincare grown so quickly?

Structural reasons more than cultural ones: products became legible by ingredient rather than by brand, online retail removed the gendered aisle, clinical positioning gained credibility, and professional treatment became discussable.

Are men's products different from women's products?

The gendered label carries no formulation information. What matters is whether a product suits high sebum output, a shaved lower face and the actual concern being addressed.

Is online prescribing for hair loss safe?

It has improved access substantially, and the quality of assessment varies. Where a prescription only medicine with a documented adverse effect profile is involved, the standard of consultation matters and is covered by professional guidance on remote prescribing.

How can I check whether a brand's claims are credible?

The Advertising Standards Authority publishes its rulings, which are searchable. Beyond that, the useful test is whether a claim names a mechanism and a concentration rather than describing an outcome.

Are skin and hair supplements worth taking?

Outside the correction of a documented deficiency, the evidence is weak. Food supplements in the UK are regulated as foods rather than medicines, so the claims permitted and the evidence required differ from those for a licensed treatment.

The weekly briefing

One email a week on male skin: what has been published, what has changed in UK guidance, and what it means in practice.

One email a week. One lead piece, what has been published, and at most one labelled placement. Never sold, never shared.